The effect of food on the pharmacokinetics of WXFL10203614, a potential selective JAK1 inhibitor, in healthy Chinese subjects

por Huang, Kai, Shi, Yunfei, Chu, Nannan, Que, Linling, Ding, Ying, Qian, Zhenzhong, Qin, Wei, Gu, Xianghong, Wang, Jiakun, Zhang, Zhiwei, Xu, Jianguo, He, Qing
Publicado 2022

LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA(®) in Chinese healthy male subjects

por Cao, Guoying, Wang, Jingjing, He, Jinjie, Hu, Yingying, Yang, Haijing, Que, Linling, Gu, Xianghong, Yu, Jicheng, Wu, Xiaojie, Wu, Jufang, Fang, Wei, He, Qing, Zhang, Jing
Publicado 2023

Safety, tolerability and pharmacokinetics of WXFL10203614 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase Ⅰ study

por Huang, Kai, Ding, Ying, Que, Linling, Chu, Nannan, Shi, Yunfei, Qian, Zhenzhong, Qin, Wei, Chen, Yuanxin, Gu, Xianghong, Wang, Jiakun, Zhang, Zhiwei, Xu, Jianguo, He, Qing
Publicado 2022

A Randomized, Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 With Bevacizumab (Avastin®) in Chinese Healthy Male Subjects

por Huang, Kai, Que, Linling, Ding, Ying, Chu, Nannan, Qian, Zhenzhong, Shi, Yunfei, Qin, Wei, Li, Zhenni, Chen, Yuanxin, Gu, Xianghong, Wang, Jiakun, Zhang, Lin, Zhang, Jisheng, Zhu, Xiangyang, Yang, Yongmin, Tang, Yuan, He, Qing
Publicado 2021